Switching from quetiapine to ziprasidone: a sixteen-week, open-label, multicenter study evaluating the effectiveness and safety of ziprasidone in outpatient subjects with schizophrenia or schizoaffective disorder.
about
Current approaches to treatments for schizophrenia spectrum disorders, part I: an overview and medical treatmentsWithdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendations.Almost all antipsychotics result in weight gain: a meta-analysis.Ziprasidone with adjunctive mood stabilizer in the maintenance treatment of bipolar I disorder: long-term changes in weight and metabolic profilesBehavioral interventions for antipsychotic induced appetite changes.Weight gain and antipsychotics: a drug safety review.Evaluation of the pharmacokinetics, safety and clinical efficacy of ziprasidone for the treatment of schizophrenia and bipolar disorder.Antipsychotic switching in schizoaffective disorder: A systematic review.Systematic Literature Review of the Methods Used to Compare Newer Second-Generation Agents for the Management of Schizophrenia: A focus on Health Technology Assessment.Long-term metabolic effects of aripiprazole, ziprasidone and quetiapine: a pragmatic clinical trial in drug-naïve patients with a first-episode of non-affective psychosis.
P2860
Q27003099-BA3741BC-5126-4595-A969-17228213A12EQ34653803-5EE09BCD-A85E-4B7F-9DAF-376723D2133EQ34661499-45DC8DF5-A7C7-42C8-8E06-310DCD23894CQ35577365-DB8D01B4-5F0B-47B4-9496-1D039056FA68Q36651040-20334E4C-D6E9-4F06-8AAA-AAD87BD6E1ECQ38268590-64F5E1CA-E06F-4211-8B42-9AD64A67CC81Q38284625-75BAB1D8-56C4-4C55-BF94-80FF1FC8E6B8Q38370545-ECA5BB13-AC15-4FE3-93C7-6D0524EEF935Q38473914-D4879633-9649-4595-8ABB-7647008D3F00Q47587816-980E4407-FEB0-42D6-A924-6805A180E50F
P2860
Switching from quetiapine to ziprasidone: a sixteen-week, open-label, multicenter study evaluating the effectiveness and safety of ziprasidone in outpatient subjects with schizophrenia or schizoaffective disorder.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Switching from quetiapine to z ...... a or schizoaffective disorder.
@en
Switching from quetiapine to z ...... a or schizoaffective disorder.
@nl
type
label
Switching from quetiapine to z ...... a or schizoaffective disorder.
@en
Switching from quetiapine to z ...... a or schizoaffective disorder.
@nl
prefLabel
Switching from quetiapine to z ...... a or schizoaffective disorder.
@en
Switching from quetiapine to z ...... a or schizoaffective disorder.
@nl
P2093
P1476
Switching from quetiapine to z ...... a or schizoaffective disorder.
@en
P2093
Idil Cavus
Mary Bachinsky
Michelle Stewart
Onur N Karayal
Phillip Chappell
Sheela Kolluri
P304
P356
10.1097/01.PRA.0000396061.05269.C8
P50
P577
2011-03-01T00:00:00Z